Loading data
HLPNasdaq
| Unit: USD | FY2025 | FY2025 | FY2024 | FY2024 | FY2023 |
|---|---|---|---|---|---|
| Revenue | 19.6 m USD | — | 14.11 m USD | — | 16 m USD |
| Cost of revenue | 13.22 m USD | — | 9.59 m USD | — | 10.75 m USD |
| Gross profit | 6.38 m USD | — | 4.52 m USD | — | 5.25 m USD |
| Research and development expense | 994.5 k USD | — | 818.31 k USD | — | 962.96 k USD |
| Selling, general and administrative expense | — | — | 6.1 m USD | — | 4.23 m USD |
| Operating profit | 2.43 m USD | — | -1.58 m USD | — | 1.02 m USD |
| Interest expense | — | — | — | — | 650.8 k USD |
| Profit before tax | 2.17 m USD | — | -1.87 m USD | — | 932.46 k USD |
| Income tax expense | 228.68 k USD | — | 8.39 k USD | — | 67.74 k USD |
| Net income (reported basis) | 1.94 m USD | — | -1.88 m USD | — | 864.72 k USD |
| Net income attributable to common shareholders | 1.94 m USD | 990.05 k USD | -1.88 m USD | -1.9 m USD | 864.72 k USD |
| Basic earnings per share | 0.03 USD/share | 0.01 USD/share | -0.11 USD/share | -0.15 USD/share | 0.07 USD/share |
| Diluted earnings per share | 0.03 USD/share | 0.01 USD/share | -0.11 USD/share | -0.15 USD/share | 0.07 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.